Drug shortages homepage
Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.
Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.
The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.
Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.
If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.
Below are the newest shortage and discontinuation reports and updates to existing ones.
LEGEND
!!T3 denotes an actual Tier 3 shortage/discontinuation
!T3 denotes an anticipated Tier 3 shortage/discontinuation
Shortage Reports
| Brand name | Company Name | Status | Strength | Update | Date Updated | View Report |
|---|---|---|---|---|---|---|
| AURO-ATOMOXETINE | AURO PHARMA INC | Resolved | 80MG | Updated Report | 2025-11-16 | 270003 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | FRESENIUS KABI CANADA LTD | Actual shortage | 2MG | Updated Report | 2025-11-15 | 271950 |
| VORICONAZOLE FOR INJECTION | FRESENIUS KABI CANADA LTD | Resolved | 200MG | Updated Report | 2025-11-15 | 271611 |
| TROMBOJECT 3% | OMEGA LABORATORIES LIMITED | Resolved | 30MG | Updated Report | 2025-11-15 | 206240 |
| QUILLIVANT ER CHEWABLE TABLETS | KYE PHARMACEUTICALS INC. | Resolved | 20MG | Updated Report | 2025-11-15 | 271115 |
| ONDISSOLVE ODF | TAKEDA CANADA INC | Resolved | 8MG | Updated Report | 2025-11-15 | 262736 |
| ONDISSOLVE ODF | TAKEDA CANADA INC | Resolved | 4MG | Updated Report | 2025-11-15 | 262746 |
| APO-AMPHETAMINE XR | APOTEX INC | Resolved | 20MG | Updated Report | 2025-11-15 | 264567 |
| APO-AMPHETAMINE XR | APOTEX INC | Resolved | 15MG | Updated Report | 2025-11-15 | 264576 |
| APO-ESOMEPRAZOLE | APOTEX INC | Actual shortage | 20MG | New Report | 2025-11-14 | 271937 |
| APO-AMPHETAMINE XR | APOTEX INC | Actual shortage | 30MG | Updated Report | 2025-11-14 | 264573 |
| APO-AMPHETAMINE XR | APOTEX INC | Actual shortage | 25MG | Updated Report | 2025-11-14 | 264570 |
| APO-AMPHETAMINE XR | APOTEX INC | Actual shortage | 10MG | Updated Report | 2025-11-14 | 264564 |
| APO-AMPHETAMINE XR | APOTEX INC | Actual shortage | 5MG | Updated Report | 2025-11-14 | 264561 |
| APO-LEVOTHYROXINE | APOTEX INC | Resolved | 50MCG | Updated Report | 2025-11-14 | 262425 |
| APO-DASATINIB | APOTEX INC | Actual shortage | 20MG | Updated Report | 2025-11-14 | 265269 |
| CLINDOXYL GEL | GLAXOSMITHKLINE INC | Resolved | 5% 1% | Updated Report | 2025-11-14 | 261877 |
| METHOTREXATE INJECTION BP | ACCORD HEALTHCARE INC | Actual shortage | 25MG | Updated Report | 2025-11-14 | 218309 |
| METHOTREXATE INJECTION BP | ACCORD HEALTHCARE INC | Actual shortage | 25MG | Updated Report | 2025-11-14 | 227100 |
| METHOTREXATE SUBCUTANEOUS | ACCORD HEALTHCARE INC | Actual shortage | 20MG | Updated Report | 2025-11-14 | 271316 |
| BREVICON 1/35 TABLETS (28-DAY PACK) | PFIZER CANADA ULC | Anticipated shortage | 1MG 0.035MG | New Report | 2025-11-14 | 271908 |
| LOVENOX HP | SANOFI-AVENTIS CANADA INC | Actual shortage | 150MG | Updated Report | 2025-11-14 | 271411 |
| IMITREX | GLAXOSMITHKLINE INC | Anticipated shortage | 5MG | New Report | 2025-11-14 | 271904 |
| IMITREX | GLAXOSMITHKLINE INC | Anticipated shortage | 20MG | New Report | 2025-11-14 | 271901 |
| ENGERIX-B | GLAXOSMITHKLINE INC | Resolved | 20MCG | Updated Report | 2025-11-14 | 269359 |
| VOLIBRIS | GLAXOSMITHKLINE INC | Avoided shortage | 5MG | Updated Report | 2025-11-14 | 267983 |
| VOLIBRIS | GLAXOSMITHKLINE INC | Avoided shortage | 10MG | Updated Report | 2025-11-14 | 267986 |
| AURO-CEPHALEXIN | AURO PHARMA INC | Actual shortage | 250MG | Updated Report | 2025-11-14 | 166586 |
| AURO-CEPHALEXIN | AURO PHARMA INC | Actual shortage | 125MG | Updated Report | 2025-11-14 | 219262 |
| ACYCLOVIR SODIUM INJECTION | EUGIA PHARMA INC. | Actual shortage | 50MG | Updated Report | 2025-11-14 | 270922 |
| EUGIA-ONDANSETRON INJECTION | EUGIA PHARMA INC. | Actual shortage | 2MG | Updated Report | 2025-11-14 | 257697 |
| DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION | EUGIA PHARMA INC. | Actual shortage | 100MCG | Updated Report | 2025-11-14 | 262460 |
| BREVIBLOC INJECTION 10MG/ML | BAXTER CORPORATION | Resolved | 10MG | Updated Report | 2025-11-14 | 263010 |
| APO-TERBINAFINE | APOTEX INC | Actual shortage | 250MG | Updated Report | 2025-11-13 | 269757 |
| APO-DORZO-TIMOP | APOTEX INC | Actual shortage | 20MG 5MG | New Report | 2025-11-13 | 271862 |
| APO-DESVENLAFAXINE | APOTEX INC | Actual shortage | 50MG | Updated Report | 2025-11-13 | 271859 |
| APO-DILTIAZ CD | APOTEX INC | Actual shortage | 240MG | New Report | 2025-11-13 | 271856 |
| APO-GABAPENTIN | APOTEX INC | Actual shortage | 600MG | New Report | 2025-11-13 | 271853 |
| APO-CLOPIDOGREL | APOTEX INC | Actual shortage | 75MG | New Report | 2025-11-13 | 271850 |
| APO-SITAGLIPTIN/METFORMIN XR | APOTEX INC | Actual shortage | 50MG 1000MG | Updated Report | 2025-11-13 | 271847 |
| APO-CLOPIDOGREL | APOTEX INC | Actual shortage | 75MG | New Report | 2025-11-13 | 271844 |
| TIMOPTIC | ELVIUM LIFE SCIENCES | Actual shortage | 0.5% | Updated Report | 2025-11-13 | 267762 |
| BIPAZEN | KVR PHARMACEUTICALS INC. | Actual shortage | 4MCG | Updated Report | 2025-11-13 | 260964 |
| PMSC-ESOMEPRAZOLE DR | PHARMASCIENCE INC | Actual shortage | 20MG | New Report | 2025-11-13 | 271837 |
| PMSC-ESOMEPRAZOLE DR | PHARMASCIENCE INC | Actual shortage | 40MG | Updated Report | 2025-11-13 | 270551 |
| TEVA-RAMIPRIL | TEVA CANADA LIMITED | Actual shortage | 10MG | New Report | 2025-11-13 | 271832 |
| TEVA-ESOMEPRAZOLE | TEVA CANADA LIMITED | Actual shortage | 20MG | Updated Report | 2025-11-13 | 264408 |
| TEVA-SUMATRIPTAN DF | TEVA CANADA LIMITED | Resolved | 100MG | Updated Report | 2025-11-13 | 263119 |
| TEVA-NAPROXEN | TEVA CANADA LIMITED | Resolved | 500MG | Updated Report | 2025-11-13 | 271205 |
| TEVA-LENOLTEC NO. 4 | TEVA CANADA LIMITED | Resolved | 60MG 300MG | Updated Report | 2025-11-13 | 255672 |
Discontinuation Reports
| Brand name | Company Name | Status | Strength | Update | Date Updated | View Report |
|---|---|---|---|---|---|---|
| CLINDOXYL GEL | GLAXOSMITHKLINE INC | Discontinued | 5% 1% | Updated Report | 2025-11-14 | 270515 |
| GLUCOPHAGE | SANOFI-AVENTIS CANADA INC | To be discontinued | 850MG | New Report | 2025-11-14 | 271873 |
| ARAVA | SANOFI-AVENTIS CANADA INC | To be discontinued | 10MG | New Report | 2025-11-14 | 271870 |
| ARAVA | SANOFI-AVENTIS CANADA INC | To be discontinued | 20MG | New Report | 2025-11-14 | 271867 |
| KIVEXA | VIIV HEALTHCARE ULC | Discontinued | 300MG 600MG | Updated Report | 2025-11-13 | 238375 |
| SANDOZ ORPHENADRINE | SANDOZ CANADA INCORPORATED | Discontinued | 100MG | New Report | 2025-11-13 | 271679 |
| VOLTAREN OPHTHA | NOVARTIS PHARMACEUTICALS CANADA INC | Discontinued | 0.1% | New Report | 2025-11-12 | 271635 |
| HUMATROPE | ELI LILLY CANADA INC | To be discontinued | 24MG 3.15ML | Updated Report | 2025-11-11 | 240682 |
| HUMATROPE | ELI LILLY CANADA INC | To be discontinued | 12MG 3.15ML | Updated Report | 2025-11-11 | 240679 |
| HUMATROPE | ELI LILLY CANADA INC | To be discontinued | 6MG 3.15ML | Updated Report | 2025-11-11 | 240676 |

